Last Updated : September 20, 2011
Details
FilesGeneric Name:
Rufinamide
Project Status:
Complete
Therapeutic Area:
Lennox-Gastaut syndrome
Manufacturer:
Eisai Limited
Call for patient/clinician input open:
Brand Name:
Banzel
Project Line:
Reimbursement Review
Project Number:
SR0252-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Lennox-Gastaut syndrome; adjunctive treatment of seizures
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : September 20, 2011